These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 5003602

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [A method for the determination of the resistance of Mycobacterium tuberculosis to classical antitubercular drugs in percentages].
    Zduńczyk-Pawelek H, Kostrzewska K, Blitek-Golc D.
    Gruzlica; 1966 Feb; 34(2):89-94. PubMed ID: 4957541
    [No Abstract] [Full Text] [Related]

  • 23. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
    Nitti V.
    Arch Monaldi; 1972 Feb; 27(4):454-74. PubMed ID: 4217601
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Incidence of drug resistance of Mycobacterium tuberculosis].
    Terentieva AS.
    Vrach Delo; 1979 Mar; (3):28-30. PubMed ID: 109992
    [No Abstract] [Full Text] [Related]

  • 26. [Bacteriostatic activity of the blood during treatment with chemotherapeutic agents and its clinical significance].
    Klebanov MA, Bibik NF.
    Probl Tuberk; 1966 Mar; 44(12):48-53. PubMed ID: 4974818
    [No Abstract] [Full Text] [Related]

  • 27. Primary resistance to the major anti-tuberculosis drugs in Ethiopia.
    Wolde K, Lemma E, Abdi A.
    Ethiop Med J; 1986 Jan; 24(1):15-8. PubMed ID: 3080312
    [No Abstract] [Full Text] [Related]

  • 28. [Bacteriostatic activity of blood in pulmonary tuberculosis after administration of different drug combinations].
    Mkrtchian SV, Shmeleva VI, Utkin VV.
    Probl Tuberk; 1976 Jan; 3():67-70. PubMed ID: 967863
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V, Muzikravić T.
    Plucne Bolesti Tuberk; 1974 Jan; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C, Andreis G.
    G Ital Chemioter; 1966 Jan; 13(1):109-27. PubMed ID: 4967318
    [No Abstract] [Full Text] [Related]

  • 32. [Primary resistance of the tubercle bacillus to antibiotics. Bacteriological and therapeutic study. Apropos of 22 cases].
    Weill G, Levy A, Guignon JP, Petion G, Lecoq H.
    Strasb Med; 1965 Mar; 16(3):165-93. PubMed ID: 4953251
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Bacteriostatic activity of blood in patients with pulmonary tuberculosis during polychemotherapy].
    Bialik IV, Klimenko MT, Ginzburg TS.
    Probl Tuberk; 1991 Mar; (5):25-9. PubMed ID: 1924237
    [Abstract] [Full Text] [Related]

  • 36. [Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis].
    Daddi G, Lucchesi M, Mancini P, Rossi P, Sbampato M, Storniello G.
    Ann Ist Carlo Forlanini; 1969 Mar; 29(4):339-48. PubMed ID: 5004332
    [No Abstract] [Full Text] [Related]

  • 37. [Early results of ethambutol treatment in patients with cavernous pulmonary tuberculosis and resistance to many antitubercular agents].
    Kamińska M, Czajka-Kropaczek L, Ciechanowska A.
    Gruzlica; 1971 Jul; 39(7):648-52. PubMed ID: 5000657
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of tuberculosis.
    Iseman MD, Goble M.
    Adv Intern Med; 1988 Jul; 33():253-65. PubMed ID: 3125723
    [No Abstract] [Full Text] [Related]

  • 39. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. 2].
    Yamamoto M.
    Kekkaku; 1970 Nov; 45(11):359-66. PubMed ID: 4992936
    [No Abstract] [Full Text] [Related]

  • 40. [Experience in treating tuberculosis patients in the IB outpatient registry group].
    Smirnov GA, Valitova ZIu, Fattakhova RM, Anastas'ev VS.
    Probl Tuberk; 1986 Nov; (4):12-5. PubMed ID: 3086863
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.